Sanofi
SNY
$59.28
$0.1250.21%
12/31/2023 | 12/31/2023 | 09/30/2023 | |||
---|---|---|---|---|---|
Net Income | -- | -- | -- | ||
Total Depreciation and Amortization | -- | -- | -- | ||
Total Amortization of Deferred Charges | -- | -- | -- | ||
Total Other Non-Cash Items | -- | -- | -- | ||
Change in Net Operating Assets | -- | -- | -- | ||
Cash from Operations | -- | -- | -- | ||
Capital Expenditure | -- | -- | -- | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -- | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | -- | -- | -- | ||
Cash from Investing | -- | -- | -- | ||
Total Debt Issued | -- | -- | -- | ||
Total Debt Repaid | -- | -- | -- | ||
Issuance of Common Stock | -- | -- | -- | ||
Repurchase of Common Stock | -- | -- | -- | ||
Issuance of Preferred Stock | -- | -- | -- | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | -- | -- | -- | ||
Cash from Financing | -- | -- | -- | ||
Foreign Exchange rate Adjustments | -- | -- | -- | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | -- | -- | -- | ||